- Medical exoskeletons, wearable robotic devices designed to assist and enhance human mobility, are becoming essential tools in rehabilitation and physical therapy, especially for patients with neurological and musculoskeletal disorders
- The rising demand for medical exoskeletons is driven by increasing prevalence of disabilities caused by stroke, spinal cord injuries, and aging populations, as well as growing adoption of robotic-assisted rehabilitation therapies that improve patient outcomes and reduce recovery time
- North America holds a significant market share of approximately 38.7% in 2024, due to the presence of advanced healthcare infrastructure, higher healthcare expenditure, and strong adoption of innovative medical technologies
- The Asia-Pacific region is expected to witness the fastest growth during the forecast period, with a market share projected to reach 29.5% by 2032, propelled by rising healthcare investments, increasing geriatric population, and expanding awareness about rehabilitation robotics in emerging economies
- Lower extremity exoskeletons dominate the market segment with a share of approximately 56.4% in 2024, due to their widespread use in gait training and mobility assistance, while advancements in AI and sensor technologies are driving the development of smarter, more adaptive exoskeleton solutions
